Biocon Shares Slump 4% as Bengaluru API Unit Gets VAI Tag
Shares of Biocon Ltd slumped 4% on Monday, 9 December, after the company’s Bengaluru Unit received an Establishment Inspection Report (EIR) with a Voluntary Action...
Tag : Biocon
Biocon Subsidiary Secures USFDA Approval
Biocon on 31 August announced that their wholly-owned subsidiary, Biocon Pharma Ltd received US Food and Drug Administration (USFDA) for its Abbreviated New Drug Application...
Biocon Biologics and Janssen Settle to Launch Biosimilar Bmab 1200, Shares Trading Flat
Shares of Biocon Ltd. are trading flat after reaching a day’s high of Rs 364.95 on 29th August. This follows the company’s announcement that its...
Biocon Shares Gain 1% on Receiving Nod from UK Health Agency
Biocon shares were trading 1% higher on 15 November after Biocon Biologics, a subsidiary of the company, announced receiving marketing authorisation from the Medicines and...
Biocon Shares Fall 4% as Malaysia Unit Red Flagged by USFDA
Shares of Biocon tumbled 4% on 18 October after the company’s Malaysia unit was red-flagged by the USFDA (US Food and Drug Administration). The company...
Biocon Q1 Report; Net Profit Tumbles by 30%; Shares Plunge 3%
The biopharmaceutical company Biocon has released its financial results for the April-June quarter for the 2023-24 fiscal year. The company reported a 30% YoY decline...
Biocon Fell 2% After Malaysia Unit Gets 6 Notes From USFDA
Biocon shares fell 2% to Rs 258.50 at 9:27 am on Monday after the company acknowledged six US Food and Drug Administration (USFDA) observations. The...
Biocon Share Soars on USFDA’s ‘No Observations’ on Bengaluru Facility
On June 5, Biocon shares opened positively, gaining 1.5% as USFDA dispensed no observations on the company’s Bengaluru facility. Biotechnology company Biocon has logged that...
Biocon Shares Soar 8% as Q4 Net Profit Rises 31%
Shares of Biocon rose nearly 8% in early trading on May 24, boosted by the drugmaker’s strong fourth-quarter earnings. The drugmaker on Tuesday posted a...
Ahan-I Sells Stake in Biocon for Rs 380 Crore
On Friday, hedge fund Ahan-I Ltd sold a 1.57% stake in pharmaceutical company Biocon for Rs 380 crore through an open market transaction. The bulk...